Different types of reactions to E7386 among colorectal cancer patient‑derived organoids and corresponding CAFs-Reference-Cited by-同舟云学术

Different types of reactions to E7386 among colorectal cancer patient‑derived organoids and corresponding CAFs

Published:2022-05-23 Issue:1 Volume:24 Page:
ISSN:1792-1074
Container-title:Oncology Letters
language:
Short-container-title:Oncol Lett

Author:

Imai Toshio¹,Naruse Mie¹,Ochiai Masako¹,Matsumoto Kenji²,Ikeda Satsuki³,Kani Manami³,Kato Yuyu³,Hirayama Akiyoshi³,Soga Tomoyoshi³,Hori Yusaku⁴,Yokoi Akira⁴,Ochiai Atsushi⁵

Affiliation:

1. Central Animal Division, National Cancer Center Research Institute, Tokyo 104‑0045, Japan

2. Department of Allergy and Clinical Immunology, National Research Institute for Child Health and Development, Tokyo 157‑8535, Japan

3. Institute for Advanced Biosciences, Keio University, Tsuruoka, Yamagata 997‑0035, Japan

4. Oncology Business Group, Eisai Co., Ltd., Tokyo 112‑8088, Japan

5. Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Tokyo 104‑0045, Japan

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Reference31 articles.

1. Colorectal cancer;Dekker;Lancet,2019

2. Colorectal cancer statistics, 2020;Siegel;CA Cancer J Clin,2020

3. A genetic model for colorectal tumorigenesis;Fearon;Cell,1990

4. The causes and consequences of genetic heterogeneity in cancer evolution;Burrell;Nature,2013

5. Heterogeneity of KRAS, NRAS, BRAF and PIK3CA mutations in metastatic colorectal cancer and potential effects on therapy in the CAPRI GOIM trial;Normanno;Ann Oncol,2015

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. E7386 is not a Specific CBP/β-Catenin Antagonist;Current Molecular Pharmacology;2023-05-29